Výsledky vyhledávání - "Nasiema Wingate-Pearse"

Correlation of pre- and post-induction plasma mutant allele fraction with progression-free survival (PFS) in STEAM, a prospective, randomized, multicenter study in metastatic colorectal cancer (mCRC)

Autor: John F. Palma, Christoph Mancao, Alan Nicholas, Carolyn Williams, May Yau, Nasiema Wingate-Pearse, Lijing Yao, Nicolas Sommer, Monica Pimentel, David Zhang, Johanna C. Bendell, John Lee, Abraham Munoz, Stephanie J. Yaung, Katrina Mayol, Herbert Hurwitz, Alexander F. Lovejoy, Ulrich Peter Rohr

Publikováno v: Journal of Clinical Oncology. 35:e15118-e15118

e15118 Background: STEAM (NCT01765582) evaluated the efficacy and safety of concurrent (c) and sequential (s) FOLFOXIRI-bevacizumab (BEV) versus FOLFOX-BEV for first-line treatment of mCRC. Methods: The AVENIO ctDNA Expanded Kit (Research Use Only) w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4691d5d12c0b622088af057a4d2f5c04
https://doi.org/10.1200/jco.2017.35.15_suppl.e15118

Zobrazit plný text záznamu

Evaluation of clinical outcomes by analysis of mutations in tumor tissue and circulating plasma DNA using next-generation sequencing (NGS) from STEAM, a prospective, randomized, multicenter study in metastatic colorectal cancer (mCRC)

Autor: Ulrich Peter Rohr, May Yau, Nasiema Wingate-Pearse, Johanna C. Bendell, Lijing Yao, David Zhang, Nicolas Sommer, Alexander F. Lovejoy, Monica Pimentel, Abraham Munoz, Alan Nicholas, John F. Palma, John Lee, Carolyn Williams, Stephanie J. Yaung, Katrina Mayol, Herbert Hurwitz, Christoph Mancao

Publikováno v: Journal of Clinical Oncology. 35:11510-11510

11510 Background: STEAM (NCT01765582) assessed the efficacy and safety of concurrent (c) and sequential (s) FOLFOXIRI-bevacizumab (BEV) vs FOLFOX-BEV for first-line treatment of mCRC. Methods: The AVENIO ctDNA Expanded Kit (Research Use Only) was use

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5149e60f0ccce1196a000da00363cba7
https://doi.org/10.1200/jco.2017.35.15_suppl.11510

Zobrazit plný text záznamu

Final Results of Anagrelide Controlled-Release (GALE-401) Safety, Efficacy and Pharmacokinetics in Subjects with Myeloproliferative Neoplasms (MPN)-Related Thrombocytosis

Autor: Phu V. Troung, Olivier Barriere, Srdan Verstovsek, Gavin S. Choy, Dmitriy Berenzon, Raul Mena, Nasiema Wingate-Pearse, Paul F. Glidden, Marc Saltzman, William Jawien, Roger M. Lyons, Alberto Bessudo, Hali E. Beeson

Publikováno v: Blood. 126:4074-4074

Introduction: Agrylin® (United States) and Xagrid® (European Union) are immediate release (IR) preparations of anagrelide hydrochloride that block megakaryocyte differentiation and proliferation and inhibit the action of cyclic AMP phosphodiesteras

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::11e097ae898fab2db48598d5af01ccaf
https://doi.org/10.1182/blood.v126.23.4074.4074

Zobrazit plný text záznamu

Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human

Autor: Douglas J. Beardsley, David Walker, Stephen A. Back, Nasiema Wingate-Pearse, A. Roger Hohimer, Andrew Craig, Ning Ling Luo

Publikováno v: Experimental neurology. 181(2)

The development of a rodent model in the perinatal rat or mouse that reproduces the principal features of human perinatal white matter injury (periventricular leukomalacia) has been hampered by uncertainty about the developmental window in the rodent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9539746170c67292531cc349ae53a9b4
https://pubmed.ncbi.nlm.nih.gov/12781996

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání